These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17539906)

  • 41. [Familial hypercholesterolemia in Tunisia].
    Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN
    Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia.
    Motazacker MM; Pirruccello J; Huijgen R; Do R; Gabriel S; Peter J; Kuivenhoven JA; Defesche JC; Kastelein JJ; Hovingh GK; Zelcer N; Kathiresan S; Fouchier SW
    Eur Heart J; 2012 Jun; 33(11):1360-6. PubMed ID: 22408029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
    Bunn CF; Lintott CJ; Scott RS; George PM
    Hum Mutat; 2002 Mar; 19(3):311. PubMed ID: 11857755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
    J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy.
    Romano M; Di Taranto MD; D'Agostino MN; Marotta G; Gentile M; Abate G; Mirabelli P; Di Noto R; Del Vecchio L; Rubba P; Fortunato G
    Atherosclerosis; 2010 Jun; 210(2):493-6. PubMed ID: 20045108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia.
    Jelassi A; Slimani A; Jguirim I; Najah M; Maatouk F; Varret M; Slimane MN
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):83-6. PubMed ID: 21115573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate.
    Graham CA; McIlhatton BP; Kirk CW; Beattie ED; Lyttle K; Hart P; Neely RD; Young IS; Nicholls DP
    Atherosclerosis; 2005 Oct; 182(2):331-40. PubMed ID: 16159606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational screening in the LDLR gene among patients presenting familial hypercholesterolemia in the Southeast of Brazil.
    Molfetta GA; Zanette DL; Santos JE; Silva WA
    Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28873201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects.
    Jannes CE; Santos RD; de Souza Silva PR; Turolla L; Gagliardi AC; Marsiglia JD; Chacra AP; Miname MH; Rocha VZ; Filho WS; Krieger JE; Pereira AC
    Atherosclerosis; 2015 Jan; 238(1):101-7. PubMed ID: 25461735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project.
    Taylor A; Wang D; Patel K; Whittall R; Wood G; Farrer M; Neely RD; Fairgrieve S; Nair D; Barbir M; Jones JL; Egan S; Everdale R; Lolin Y; Hughes E; Cooper JA; Hadfield SG; Norbury G; Humphries SE
    Clin Genet; 2010 Jun; 77(6):572-80. PubMed ID: 20236128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia - a proof-of-concept study.
    Maurer F; Pradervand S; Guilleret I; Nanchen D; Maghraoui A; Chapatte L; Bojkowska K; Bhuiyan ZA; Jacquemont N; Harshman K; Mooser V
    Swiss Med Wkly; 2016; 146():w14326. PubMed ID: 27497240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The management of familial hypercholesterolaemia in Morocco.
    El Messal M; Aït Chihab K; Chater R; Loutfi M; Kettani A; Hafidi A; Adlouni A
    Acta Cardiol; 2006 Oct; 61(5):551-5. PubMed ID: 17117756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update of the Portuguese Familial Hypercholesterolaemia Study.
    Medeiros AM; Alves AC; Francisco V; Bourbon M;
    Atherosclerosis; 2010 Oct; 212(2):553-8. PubMed ID: 20828696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective.
    Laurie AD; Scott RS; George PM
    Atheroscler Suppl; 2004 Dec; 5(5):13-5. PubMed ID: 15556094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia.
    Thiart R; Varret M; Lintott CJ; Scott RS; Loubser O; du Plessis L; de Villiers JN; Boileau C; Kotze MJ
    Mol Cell Probes; 2000 Oct; 14(5):299-304. PubMed ID: 11040093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Familial hypercholesterolaemia in Portugal.
    Bourbon M; Alves AC; Medeiros AM; Silva S; Soutar AK;
    Atherosclerosis; 2008 Feb; 196(2):633-42. PubMed ID: 17765246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia.
    Jelassi A; Jguirim I; Najah M; Abid AM; Boughamoura L; Maatouk F; Rouis M; Boileau C; Rabès JP; Slimane MN; Varret M
    Atherosclerosis; 2009 Apr; 203(2):449-53. PubMed ID: 18757057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family.
    Garcia-Garcia AB; Ivorra C; Martinez-Hervas S; Blesa S; Fuentes MJ; Puig O; Martín-de-Llano JJ; Carmena R; Real JT; Chaves FJ
    Atherosclerosis; 2011 Oct; 218(2):423-30. PubMed ID: 21868016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencing.
    Han SM; Hwang B; Park TG; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo J; Hur SH; Jeong JO; Park S; Jang Y; Lee MG; Bang D; Lee JH; Lee SH
    PLoS One; 2015; 10(5):e0126706. PubMed ID: 25962062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.